Dr. Kirschling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 Dewey Street
Wisconsin Rapids, WI 54494Phone+1 715-421-7442
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1982 - 1985
- San Antonio Uniformed Services Health Education ConsortiumInternship, Transitional Year, 1979 - 1980
- Medical College of WisconsinClass of 1979
Certifications & Licensure
- MN State Medical License 1992 - 2025
- WI State Medical License 1997 - 2025
- TX State Medical License 1980 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsMitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.James N. Ingle, Carl G. Kardinal, Vera J. Suman, Michael H. Veeder, Paul L. Schaefer
Breast Cancer Research and Treatment. 1997-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: